Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Clinical trial NCT01168232 · COMPLETED
Trial details
- NCT number
- NCT01168232
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-07
- Primary completion
- 2013-11-26
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.